| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.13T | 779.71B | 486.51B | 560.19B | 416.90B |
| Gross Profit | 726.11B | 445.08B | 246.03B | 319.06B | 235.91B |
| EBITDA | 522.09B | 257.13B | 105.63B | 193.38B | 131.59B |
| Net Income | 375.35B | 161.18B | 62.29B | 130.40B | 87.30B |
Balance Sheet | |||||
| Total Assets | 1.17T | 854.21B | 671.23B | 600.22B | 494.70B |
| Cash, Cash Equivalents and Short-Term Investments | 339.97B | 262.54B | 106.70B | 85.54B | 116.58B |
| Total Debt | 20.19B | 93.50B | 94.44B | 50.84B | 43.46B |
| Total Liabilities | 376.09B | 347.67B | 240.05B | 231.53B | 200.07B |
| Stockholders Equity | 795.73B | 506.54B | 431.18B | 368.69B | 294.62B |
Cash Flow | |||||
| Free Cash Flow | 302.17B | 268.56B | 12.13B | 46.64B | 60.67B |
| Operating Cash Flow | 335.18B | 285.97B | 32.67B | 70.22B | 78.89B |
| Investing Cash Flow | -34.55B | -42.19B | -27.94B | -26.71B | -46.91B |
| Financing Cash Flow | -230.55B | -82.82B | 10.76B | -77.43B | -68.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥3.87T | 67.46 | 53.12% | 1.11% | 12.01% | 26.66% | |
80 Outperform | ¥7.84T | 38.72 | 25.78% | 0.79% | 11.08% | 9.32% | |
79 Outperform | ¥21.57T | 19.86 | 26.01% | 1.79% | 0.49% | 6.10% | |
78 Outperform | ¥19.40T | 29.12 | 47.37% | 0.25% | 44.75% | 135.64% | |
78 Outperform | ¥1.94T | 15.60 | 21.73% | 2.29% | -4.28% | -9.67% | |
77 Outperform | ¥712.60B | 24.84 | 12.66% | 2.28% | 7.69% | -19.63% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |